Additionally, some patients may voice concerns about perceived risks associated with supplemental imaging, such as increased potential for false positives or radiation exposure. It is crucial that providers are prepared to answer patient questions about the risks and benefits of supplemental imaging, so that patients may make an informed decision about what is best for them individually.

Looking ahead, I am optimistic that the updated breast tissue density MQSA requirements will encourage and support the earlier detection of breast cancers that may have otherwise been masked by dense breast tissue. However, implementation of these new rules will need to be done on a center-by-center basis to ensure that their patient population is best supported throughout the transition. By reviewing a facility’s specific needs, communicating efficiently, and considering any barriers to screenings, care teams can continue to offer patient-centric care.


About the author: Dr. Susan Harvey is currently the Vice President of Corporate Global Medical Affairs at Hologic, a medical technology innovator focused primarily on women’s health. She joined the organization in April 2019, and her current goal is to help elevate women’s health and wellbeing worldwide. That includes her leadership role with the Hologic Global Women’s Health Index, the most comprehensive survey – conducted in partnership with Gallup – about women’s health. The Index provides a science-backed, data-driven roadmap for countries to improve the wellbeing of women and girls.

Back to HCB News

Women's Health Homepage